Pelthos Therapeutics Inc. (PTHS) Misses Q1 EPS by 258c

Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q1 EPS of ($3.09), $2.58 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $10.91 million.

For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Applied Industrial Technologies (AIT) PT Raised to $400 at DA Davidson
• DA Davidson Reiterates Buy Rating on Citizens Financial Group (CFG)